The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease
- PMID: 33009177
- DOI: 10.1097/MEG.0000000000001767
The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease
Comment in
-
Reply to the letter to the Editor: 'The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease'.Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):300-302. doi: 10.1097/MEG.0000000000001777. Eur J Gastroenterol Hepatol. 2021. PMID: 33369958 No abstract available.
Comment on
-
The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease.Eur J Gastroenterol Hepatol. 2020 May;32(5):581-587. doi: 10.1097/MEG.0000000000001674. Eur J Gastroenterol Hepatol. 2020. PMID: 31922975
References
-
- Mantaka A, Tsoukali E, Fragkaki M, Karmiris K, Viazis N, Mantzaris GJ, Koutroubakis IE. The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2020; 32:581–587
-
- Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980; 1:514
-
- Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005; 353:2462–2476
-
- Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011; 106:741–747
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
